Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples